Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Melissa Kerkau"'
Autor:
Ami Patel, Karuppiah Muthumani, Jingjing Jiang, David C. Montefiori, Guido Ferrari, Sarah T. C. Elliott, Edgar Tello-Ruiz, Ziyang Xu, Janess M. Mendoza, David B. Weiner, Melissa Kerkau, Charles Beck, Aspen Trautz, Paul Fisher, Daniel W. Kulp, Laurent Humeau, Sophie Kim, Stephany J. Ramos, Kate E. Broderick, Neethu Chokkalingam, Trevor R.F. Smith, Megan C. Wise
Publikováno v:
J Clin Invest
Interventions to prevent HIV-1 infection and alternative tools in HIV cure therapy remain pressing goals. Recently, numerous broadly neutralizing HIV-1 monoclonal antibodies (bNAbs) have been developed that possess the characteristics necessary for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85e030b350c055155d9a791d0a9c5fb
https://pubmed.ncbi.nlm.nih.gov/31697648
https://pubmed.ncbi.nlm.nih.gov/31697648
Autor:
Melanie Mackay, Jennifer L. Kirchherr, Marcella Sarzotti-Kelsoe, Leila K. Needham, Susan L. Stager, John Bainbridge, Guido Ferrari, Susan A. Fiscus, Takesha McMillion, Thomas N. Denny, Barton F. Haynes, Kristy O. Long, Wendy S. Stevens, Kelly A. Soderberg, Clive M. Gray, Niranjini Moodley, Wes Rountree, Pauline Mokgotho, Raul Louzao, Melissa Kerkau, Whitney Binz
Publikováno v:
Journal of Immunological Methods. 409:21-30
The Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium was established to determine the host and virus factors associated with HIV transmission, infection and containment of virus replication, with the goal of advancing the development of an H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e92831528988438ed9505a9a7560cbc
https://doi.org/10.1016/j.jim.2014.05.013
https://doi.org/10.1016/j.jim.2014.05.013
Autor:
Cynthia L Gay, Ashley J Mayo, Chelu K Mfalila, Haitao Chu, Anna C Barry, JoAnn D Kuruc, Kara S Mcgee, Melissa Kerkau, Joe Sebastian, Susan A Fiscus, David M Margolis, Charles B Hicks, Guido Ferrari, Joseph J Eron
Publikováno v:
AIDS. 25:941-949
OBJECTIVE Characterize responses to non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral treatment (ART) initiated during acute HIV infection (AHI). DESIGN This was a prospective, single-arm evaluation of once-daily, co-formula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f33041463999d2801a0318588ed7678d
https://doi.org/10.1097/qad.0b013e3283463c07
https://doi.org/10.1097/qad.0b013e3283463c07
Autor:
Jon Cook, Charles B. Hicks, Bruce Coon, Richard Hutt, Margaret A. Fischl, David Pearson, Jan Clark, Candida T. Talabucon, Carol L. Brosgart, Joan Dragavon, Laura Ponticello, Janet Devine, Eugene Sun, Melissa Kerkau, Daniel C. Rodrigue, Donna Thee, Jeanne Berg, Mario Guerrero, Lyle Oshita, Jane L. Norris, Judy Aberg, Mark I. Becker, John Fuchs, Pablo Tebas, Guillermo J. Vázquez, Pamposh Kaul, Antoinette Kenton, Phyllis Barnett, Pascal J. de Caprariis, Michael Royal, Michelle Jack, Ann Walawander, Harold A. Kessler, Scott Souza, Sharon Shriver, Genice Hamilton, Susan E. Cohn, Hailong Cheng, John G. Gerber, Monica Millard, Sherree Wright, Linh Ngo, Gildon N. Beall, Debra Ogata-Arakaki, John Mc Neil, David M. Mushatt, Courtney V. Fletcher, Charles van der Horst, Karen Waterman, Ileana Lopez, David Katzenstein, Robert J. Fass, Joseph J. Eron, Edward P. Acosta, Stephen W. Lagakos, Hilda Mendoza, Jim Bruce, Michael F. Para, Sally Snyder, Mary Shoemaker, Mark A. Beilke, Tammy Powell, Margaret Nelson, Juan J.L. Lertora, Liliana Aguinada, Virginia Ramirez, M. Graham Ray, William W. Freimuth, Brenda Greenhill, Beverly Putnam, Aouie Carrera, Mary Albrecht, Michael F. Giordano, Stuart Carr, John M. Leedom, Charlotte Mills, Charles J. Gonzalez, Rebecca Becker, Richard Haubrich, Elizabeth Gimbel, D. Baker, Vivian Yuan, Andrea Weiss, Hongyu Jiang, Cheryl N. Karol, Kim Ingersol, Russell Strada, Paulette Mac Dougall, Carla Pettinelli, Glenna M. Auerback, Alice F. Mercado, Frances Canchola, Chris Helker, Susan A. Fiscus, X. Joan Hu, Janine R. Maenza, Henry S. Sacks, Robert Kalajian, Debbie Slamowitz, Robin Shepard, Margo Heath-Chiozzi, Michael J. Borucki, Ana Martinez, Olivia T. Ortiz, Suzanne Fiorillo, Jorge Santana, Michael S. Saag, Dena Duran, Steve Nowling, Jeff Taylor, Kristine Todd, Robert W. Coombs, Douglas D. Richman, Thomas C. Merigan, Robert Delapenha, Kenneth Wood, Harvey M. Friedman, Joseph Pulvirenti, Don Craven, Timothy W. Schacker, Ronald Swanstrom, Neel French, Judith Feinberg, Mark A. Jacobson, Judith Brown, Joseph Wheat, Ross G. Hewitt, James F. Rooney, Scott A. Smith, Bruce Peel, Doris Shank, Lisa Alexis, Roy M. Gulick, Andrea Christopher Belschner, Linda Meixner
Publikováno v:
The Journal of Infectious Diseases. 186:626-633
The 24-week extension of AIDS Clinical Trials Group Protocol 359, a study of human immunodeficiency virus (HIV)‐infected, indinavir-experienced patients, was designed to study the durability of “salvage” treatment regimens. Patients received sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca3b1c2613fffeb024856928c7b68a2
https://doi.org/10.1086/342681
https://doi.org/10.1086/342681
Autor:
Christopher B, Hurt, Sandra I, McCoy, Joann, Kuruc, Julie Ae, Nelson, Melissa, Kerkau, Susan, Fiscus, Kara, McGee, Joseph, Sebastian, Peter, Leone, Christopher, Pilcher, Charles, Hicks, Joseph, Eron
Publikováno v:
Antiviral therapy. 14(5)
Transmitted drug resistance (TDR) limits antiretroviral options and thus complicates the management of HIV-positive patients. HIV disproportionately affects the southern US, but available national estimates of TDR prevalence principally reflect large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac908cbf4bc8eab450e8bc7d62e14c26
https://pubmed.ncbi.nlm.nih.gov/19704170
https://pubmed.ncbi.nlm.nih.gov/19704170
Autor:
Shu Chen, Susan A. Fiscus, Som Siharath, Melissa Kerkau, Newton Kumwenda, Taha E. Taha, John L. Schmitz, Donald R. Hoover, Paul Alabanza
The cost for the Roche Monitor assay kit can be reduced 50% by using only the 1:1, 1:25, and 1:625 human immunodeficiency virus (HIV) and the 1:1 quantitation standard dilutions. This abbreviated test applied to 1,774 mostly African samples had resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d61cc58c2a651de843e9e4b626778b3
https://europepmc.org/articles/PMC1234002/
https://europepmc.org/articles/PMC1234002/
Autor:
Sandra I. McCoy, Susan A. Fiscus, Christopher D. Pilcher, Kara S. McGee, Christopher B. Hurt, Joseph Sebastian, Joseph J. Eron, Julie A. E. Nelson, Melissa Kerkau, Charles B. Hicks, Joann D. Kuruc, Peter A. Leone
Publikováno v:
Scopus-Elsevier
Background Transmitted drug resistance (TDR) limits antiretroviral options and thus complicates the management of HIV-positive patients. HIV disproportionately affects the southern US, but available national estimates of TDR prevalence principally re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da1899569321ba7154dbd0b9e8dc1a1
http://www.scopus.com/inward/record.url?eid=2-s2.0-69849107234&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-69849107234&partnerID=MN8TOARS